4 months ago
FULC
AnalystsEdward TenthoffEdward Tenthoff's Stock Forecasts
AnalystsEdward Tenthoff
Sectors:
Analyst Ranking
Top 27%
#1146 out of 4227 analysts
Average Return
+0.76%
Win Rate
44%47 out of 108
Risk vs Reward
Poor
Good
Edward Tenthoff's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Omega Therapeutics IncOMGA | +267.18% | $2.62 | $9.62 | 2022-05-23 - 2023-05-22 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +249.48% | $3.84 | $13.42 | 2017-11-27 - 2018-11-27 | Strong Buy |
Moderna IncMRNA | +187.99% | $143.66 | $413.72 | 2021-03-15 - 2021-08-06 | Strong Buy |
Dyne Therapeutics IncDYN | +166.35% | $5.23 | $13.93 | 2022-05-23 - 2023-05-22 | Strong Buy |
Moderna IncMRNA | +158.79% | $159.87 | $413.72 | 2021-04-15 - 2021-08-06 | Strong Buy |
Edward Tenthoff Analyst Color
Get additional color on Edward Tenthoff's coverage of popular stocks
5 months ago
STRO
5 months ago
MRNA
5 months ago
ALNY
7 months ago
RAPT
8 months ago
ASLN
9 months ago
MCRB
9 months ago
LIFE
10 months ago
PSTX
a year ago
CRSP
a year ago
ALNY
2 years ago
ARGX
2 years ago
MRNA
Edward Tenthoff's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atyr Pharma IncLIFE | 5 | Strong Buy | $13.00 | +453.19% | Maintains | 2 months ago |
Tempest Therapeutics IncTPST | 2 | Strong Buy | $6.00 | +224.32% | Maintains | 2 months ago |
Omega Therapeutics IncOMGA | 3 | Strong Buy | $10.00 | +28.21% | Maintains | 3 months ago |
Aslan Pharmaceuticals LtdASLN | 3 | Strong Buy | $15.00 | +283.63% | Maintains | 3 months ago |
Galera Therapeutics IncGRTX | 1 | Strong Buy | $6.00 | +97.37% | Initiates Coverage On | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 5 | Strong Buy | $52.00 | +54.76% | Maintains | 4 months ago |
Fulcrum Therapeutics IncFULC | 2 | Strong Buy | $21.00 | +621.65% | Maintains | 4 months ago |
Sutro Biopharma IncSTRO | 3 | Strong Buy | $18.00 | +267.35% | Maintains | 5 months ago |
Century Therapeutics IncIPSC | 3 | Strong Buy | $14.00 | +362.05% | Maintains | 5 months ago |
Fate Therapeutics IncFATE | 3 | Hold | $12.00 | +133.92% | Downgrades | 5 months ago |
Syros Pharmaceuticals IncSYRS | 2 | Strong Buy | $20.00 | +440.54% | Maintains | 5 months ago |
Jounce Therapeutics IncJNCE | 3 | Strong Buy | $5.00 | +165.96% | Maintains | 5 months ago |
Moderna IncMRNA | 7 | Strong Buy | $217.00 | +71.89% | Maintains | 5 months ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $78.00 | +23.55% | Maintains | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 3 | Strong Buy | $253.00 | +34.39% | Maintains | 5 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $3.00 | +49.25% | Initiates Coverage On | 6 months ago |
Arvinas IncARVN | 4 | Strong Buy | $81.00 | +255.42% | Maintains | 6 months ago |
Cue Biopharma IncCUE | 1 | Strong Buy | $7.00 | +79.03% | Initiates Coverage On | 6 months ago |
Aravive IncARAV | 1 | Strong Buy | $2.00 | +26.58% | Maintains | 7 months ago |
Rapt Therapeutics IncRAPT | 4 | Strong Buy | $34.00 | +67.08% | Maintains | 7 months ago |
Kronos Bio IncKRON | 3 | Strong Buy | $7.00 | +345.86% | Maintains | 7 months ago |
Nextcure IncNXTC | 2 | Strong Buy | $6.00 | +248.84% | Maintains | 7 months ago |
Gritstone Bio IncGRTS | 1 | Strong Buy | $6.00 | +250.88% | Initiates Coverage On | 7 months ago |
Seres Therapeutics IncMCRB | 3 | Strong Buy | $9.00 | +90.27% | Maintains | 9 months ago |
Mesoblast LtdMESO | 1 | Strong Buy | $7.00 | +92.84% | Initiates Coverage On | 9 months ago |
Puretech Health PLCPRTC | 1 | Strong Buy | $44.00 | +62.54% | Maintains | 9 months ago |
Poseida Therapeutics IncPSTX | 2 | Strong Buy | $11.00 | +362.18% | Maintains | 10 months ago |
Opko Health IncOPK | 2 | Strong Buy | $4.00 | +183.69% | Maintains | 10 months ago |
Crispr Therapeutics AgCRSP | 3 | Strong Buy | $121.00 | +87.13% | Maintains | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $42.00 | N/A | Maintains | a year ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $43.00 | N/A | Maintains | a year ago |
Infinity Pharmaceuticals IncINFI | 3 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Eloxx Pharmaceuticals IncELOX | 2 | Strong Buy | $60.00 | N/A | Maintains | a year ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $37.00 | N/A | Maintains | a year ago |
Aeglea Biotherapeutics IncAGLE | 1 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Aptevo Therapeutics IncAPVO | 3 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
Milestone Pharmaceuticals IncMIST | 2 | Strong Buy | $10.00 | N/A | Upgrades | a year ago |
Argenx SeARGX | 3 | Strong Buy | $354.00 | N/A | Upgrades | 2 years ago |
Synlogic IncSYBX | 1 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $323.00 | N/A | Maintains | 2 years ago |
Point Biopharma Global IncPNT | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Chemocentryx IncCCXI | 1 | Hold | $25.00 | N/A | Downgrades | 2 years ago |
Exelixis IncEXEL | 1 | Strong Buy | $36.00 | N/A | Maintains | 2 years ago |
Kaleido Biosciences IncKLDO | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Gamida Cell LtdGMDA | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Ra Medical Systems IncRMED | 3 | Hold | $25.00 | N/A | Maintains | 3 years ago |
Marker Therapeutics IncMRKR | 2 | Hold | $25.00 | N/A | Downgrades | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Strong Buy | $18.50 | N/A | Reiterates | 3 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $3.00 | N/A | Initiates Coverage On | 3 years ago |
Igm Biosciences IncIGMS | 1 | Strong Buy | $53.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $75.00 | N/A | Upgrades | 5 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Oncomed Pharmaceuticals IncOMED | 1 | Hold | $5.00 | N/A | Downgrades | 6 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.